Home › Cancer (all types) › NCT01518400
LIFE Cancer Survivorship Database for Pediatric Cancer
A Research Database for Survivors of Childhood Cancer
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Been diagnosed with cancer or similar disease * Been diagnosed with cancer at 21 years of age or younger * Be currently off treatment and disease free
About the study
The purpose of this study is to develop a mechanism for utilizing the comprehensive clinical database of childhood cancer survivors at Childrens Hospital Los Angeles (CHLA) for research purposes. Using clinical information obtained from follow-up visits of childhood cancer survivors, the database will focus on interventions to improve health status and health-related quality of life in childhood cancer survivors. This study allows for establishment and analyses of a research database for LIFE survivors by the investigators listed herein. Over the last three decades, there has been marked improvement in survival following childhood cancer, with 5-year survival rates now approaching 80%. However, the use of cancer therapy at an early age can result in complications that may not be apparent until years later as the child matures. These resulting complications, called late effects, are principally related to the specific therapy employed and the age of the child at the time the therapy was administered. Late effects may affect virtually every body system and substantially impair quality of life. As many as two-thirds of childhood cancer survivors develop at least one late effect as a result of treatment, and approximately one-third have a late effect classified as severe or life threatening.
Sponsor: Children's Hospital Los Angeles · Participants: 5,000 · Started: 2009-02
Contact the study team
- Lina Gov · Phone: 3234488598
Official record on ClinicalTrials.gov — NCT01518400
Locations in the U.S.
| California | Children's Hospital Los Angeles, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.